Assets in USD of Neumora Therapeutics, Inc. from Q4 2022 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Neumora Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2022 to Q3 2025.
Neumora Therapeutics, Inc. Assets for the quarter ending September 30, 2025 was $178M, a 49.6% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Neumora Therapeutics, Inc. Quarterly Assets (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$178M	-$175M	-49.6%	Sep 30, 2025	10-Q	2025-11-06
Q2 2025	$224M	-$181M	-44.7%	Jun 30, 2025	10-Q	2025-08-06
Q1 2025	$257M	-$193M	-43%	Mar 31, 2025	10-Q	2025-05-12
Q4 2024	$317M	-$179M	-36.1%	Dec 31, 2024	10-Q	2025-11-06
Q3 2024	$353M	-$192M	-35.3%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$404M			Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$450M			Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$496M	+$70M	+16.4%	Dec 31, 2023	10-K	2025-03-03
Q3 2023	$545M			Sep 30, 2023	10-Q	2023-11-01
Q4 2022	$426M			Dec 31, 2022	10-K	2024-03-07

* An asterisk sign (*) next to the value indicates that the value is likely invalid.